Inspection Record

Galaxy Surfactants Ltd. — FDA 483 Findings

US FDAInspected 2018-03-30Published 2018-06-28 9 findingsStability and storageOther quality systemTraining and personnelCleaning validationEquipment and facilityDocumentation and recordsQuality unit oversight

View the regulator's official source The source document is always the basis for judgement.

Findings

1Stability and storage

Your firm failed to (adequately) validate the analytical method for stability studies ofAPI, to support the intended commercialization period and expiry.

2Other quality system

Your firm failed to use water that is suitable for manufacturing ofAPI, ahi Specifically, ; ; You manufacture water water) at your site from municipality water.

3Training and personnel

Your firm failed to provide GMP training to your employees at the particular operations that the employee performs and GMP as it relates to the employee's functions.

4Cleaning validation

Your firm failed to establish anappropriate equipment cleaning procedure to assure an adequate cleaning of equipment and its subsequent release for use in the manufacture ofintermediates and APIs.

5Equipment and facility

Your firm failed to conduct appropriate qualification (DQ, IQ, OQ & PQ) of critical equipment.

6Other quality system

Your APQR procedure is deficient such that: —_ a.

7Documentation and records

You do not ensure product quality uniformity from batch to batch such that your Batch Manufacturing Records (BMR) does not conform to the Master Formula Record (MFR).

8Quality unit oversight

The responsibilities and procedures applicable to the quality control unit are not in writing and fully followed.

9Stability and storage

You failed to place on stability at least one batch per year ofmanufactured APIs and to test at least annually to confirm the stability characteristics ofthe APIs, appropriate storage conditions and confirm the expiry dates.

About this record

Extracted automatically from the document US FDA published on 2018-06-28. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

Other records for this company

Galaxy Surfactants Ltd. company profile — full history US FDA documents, 2018 Go to Findings search